AzTrials
AzTrials

Bladder Cancer Patients Candidate for Radical CystectomyNCT04502498

Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.

An observational study of Bladder Cancer Patients Candidate for Radical Cystectomy, run by Kasr El Aini Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Preoperative subclinical DVT screening in locally advanced bladder cancer patients candidate for radical cystectomy. Read more about this study

Who is it for?
Any age
What is being tested?
Lower limb duplex & doppler
How many people
60 participants
Where
No sites listed yet
Study dates
1 Oct 2020to 1 Oct 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Locally advanced Bladder cancer patients candidate for radical cystectomy and with no symptoms of DVT

Who may be able to join

  • any age
  • Any sex
  • Muscle invasive bladder cancer local advanced patients candidate for radical cystectomy

Who cannot join

  • Unfit patients
  • any contraindication for surgery
  • obese
  • coagulopathy
  • bedridden

About this study

Official title: Preoperative Detection of Subclinical Lower Limb Deep Venous Thrombosis in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy

Preoperative subclinical DVT screening in locally advanced bladder cancer patients candidate for radical cystectomy.

Read the detailed description

60 patient with local advanced bladder cancer are subjected to preoperative lower limb duplex within 1 week preoperative to radical cystectomy

Being tested
Lower limb duplex & doppler

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lower limb duplex & dopplerDiagnostic test

    Lower limb duplex and doppler one week before radical cystectomy

Study groups in NCT04502498
Study groupRoleWhat they receive
60 patients with local advanced bladder cancerLocal advanced bladder cancer patients candidate for radical cystectomy
Receives: Diagnostic Test: Lower limb duplex & doppler

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preoperative subclinical DVT

    Asymptomatic patients candidate for radical cystectomy

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2020
  2. Study start1 Oct 2020 (estimated)
  3. Primary completion1 Jun 2021 (estimated)
  4. Study completion1 Oct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04502498
Sponsor's protocol ID
Cairo University Hospital
Status last verified
Aug 2020
First submitted
4 Aug 2020
Last updated
10 Aug 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bladder Cancer Patients Candidate for Radical Cystectomy, run by Kasr El Aini Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preoperative subclinical DVT (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in